University Medical Center Groningen
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1614-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.umcg.nl
European Trial of Adjuvant Oral Glucocorticoid Pulse Therapy in Pemphigus
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-08-08
- Last Posted Date
- 2007-08-30
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 60
- Registration Number
- NCT00127764
- Locations
- π³π±
Department of Dermatology, University Medical Center Groningen, Groningen, Netherlands
Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-02-15
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 84
- Registration Number
- NCT00103792
- Locations
- π³π±
University Medical Centre Groningen, Groningen, Netherlands
Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase 2
- Conditions
- First Posted Date
- 2004-07-29
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 25
- Registration Number
- NCT00002688
- Locations
- π³π±
Academisch Medisch Centrum, Amsterdam, Netherlands
π³π±Academisch Ziekenhuis Groningen, Groningen, Netherlands
π³π±Academisch Ziekenhuis Maastricht, Maastricht, Netherlands
Β© Copyright 2024. All Rights Reserved by MedPath